Dermata Therapeutics, Inc.DRMANASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank60
3Y CAGR-60.5%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-60.5%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.13 | +373.7% |
| 2023 | 0.03 | -97.5% |
| 2022 | 1.13 | -47.7% |
| 2021 | 2.15 | +258.1% |
| 2020 | -1.36 | +93.4% |
| 2019 | -20.57 | - |